The 7th Latin American Conference on Lung Cancer (LALCA) took place on 25–27 August 2016 at the Riu Plaza Panama, Panama City, Panama. LALCA was hosted by the International Association for the Study of Lung Cancer (IASLC).
Boehringer Ingelheim hosted a satellite symposium entitled, ‘Treatment updates in NSCLC: Translating evidence into clinical practice’. The meeting was chaired by Prof. Carlos Silva, and included presentations given by Prof. Oscar Gerardo Arrieta Rodríguez and Dr Noemí Reguart.
For more details see below.
The full LALCA programme can be found here.
LALCA 2016 Industry symposium
Treatment updates in NSCLC: Translating evidence into clinical practice
Friday 26 August, 13:30–14:30
13:30 – 13:40
Welcome, introductions and opening presentation
13:40 – 14:10
Treatment considerations for first-line EGFR M+ NSCLC: irreversible ErbB Family blockade
14:10 – 14:25
Anti-angiogenic inhibition in NSCLC: From trial to practice
Oscar Gerardo Arrieta Rodríguez
14:25 – 14:30
Final questions, summary and meeting close
Click here to view the invitation
Click here to view the book of abstracts